Leveraging our technical, commercial and operational expertise to make investments that advance the current standard of care for patients and improve population health

/ / /

Gurnet Point Capital, headquartered in Cambridge, MA, was founded in 2015, and pursues control-oriented investments in scientifically de-risked life sciences businesses. Gurnet Point utilizes an active ownership strategy, deploying its financial capabilities, technical knowledge and ability to implement operational improvements to generate value.

/ / /

The Firm was created by B-FLEXION (formerly known as Waypoint Capital), a private, entrepreneurial investment firm founded by Ernesto Bertarelli. Gurnet Point’s team is comprised of experienced investment professionals, led by Senior Partners – Travis Wilson, Ron Cami and Stacey Seltzer – who are supported by a team with both investment and operational backgrounds.

/ / /

Team

Gurnet Point Capital’s diverse team brings more than 100 years of combined operational experience within life sciences and a strong track record of investing, building value and successfully monetizing late-stage life sciences businesses.

 

Discover the team